The world is currently experiencing a huge challenge which has affected all the industries and markets. Few markets have experienced a high growth in their demand while others have faced a downfall. The extent of growth or drop in the market statistics of different industries by COVID 19 plays an important role in how the future of businesses will shape up in the near future. We at Value Market Research provide you with an impact analysis of COVID 19 on this market with its latest update in the purchased version of the report.
Global Diabetes Pen Market Report By Indication (Type I Diabetes, Type II Diabetes), By Product Type (Pens, Insulin Pen Needles), By Types (Disposable, Reusable), By Therapy (Insulin, Glucagon-like Peptide-1, Growth Hormones, Fertility, Osteoporosis, Others), By End Users (Hospitals, Clinics, Home Care Settings) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028
ID:VMR11214736
April 2021
Report Formats:
The global demand for Diabetes Pen Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Diabetes pen also referred to as insulin pen, is used to inject insulin, a vital hormone for people who have diabetes. The pens allow simple, accurate, less intrusive, and convenient insulin delivery than a vial and syringe. There are two categories of pens available: disposable pen and reusable. If using a disposable pen, the needle is replaced after each injection. At the same time, if reusable, it lasts for several years with proper care. Unused and new insulin pens are to be stored in the refrigerator. The needle length and thickness vary depending on the brand. Few factors to be considered when choosing a specific brand are the size of insulin dose, durability, material, dexterity, etc.
Market Dynamics
The rapidly increasing percentage of diabetics and the need for a safe, convenient, and less intrusive approach to inject insulin are the primary trending factors for market growth. The demand for these diabetes pens is on the rise as people using them are more confident about their dose accuracy. The pens considered very easy to use by the geriatric population and children will benefit market growth. These pens, highly preferred by people with finger dexterity problems and reduced vision, will enhance the market share. Availability of smart pens that can calculate appropriate doses of insulin and provide a report on insulin usage for the user to download will be a market booster. High costs and lack of coverage by certain insurance providers are few barriers to the market's growth.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of diabetes pen. The growth and trends of diabetes pen industry provide a holistic approach to this study.
Market Segmentation
This section of the diabetes pen market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Indication
This section covers the regional outlook, which accentuates current and future demand for the Diabetes Pen market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Diabetes Pen Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the diabetes pen market include AstraZeneca, BD, Eli Lilly and Company, Biocon, Sanofi, delfu-medical.com., Owen Mumford., Wockhardt Limited (India), Smiths Group plc, P&B Pharmaceuticals Ltd., Nipro Medical Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
METHODOLOGY:
This market research report has been produced by gathering information based on primary and secondary research. Secondary research has been done using various sources, including (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. Additionally, our team conducts extensive primary research with key industry participants to gather first-hand data. The data is then analyzed and validated by industry experts.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
Diabetes pen also referred to as insulin pen, is used to inject insulin, a vital hormone for people who have diabetes. The pens allow simple, accurate, less intrusive, and convenient insulin delivery than a vial and syringe. There are two categories of pens available: disposable pen and reusable. If using a disposable pen, the needle is replaced after each injection. At the same time, if reusable, it lasts for several years with proper care. Unused and new insulin pens are to be stored in the refrigerator. The needle length and thickness vary depending on the brand. Few factors to be considered when choosing a specific brand are the size of insulin dose, durability, material, dexterity, etc.
Market Dynamics
The rapidly increasing percentage of diabetics and the need for a safe, convenient, and less intrusive approach to inject insulin are the primary trending factors for market growth. The demand for these diabetes pens is on the rise as people using them are more confident about their dose accuracy. The pens considered very easy to use by the geriatric population and children will benefit market growth. These pens, highly preferred by people with finger dexterity problems and reduced vision, will enhance the market share. Availability of smart pens that can calculate appropriate doses of insulin and provide a report on insulin usage for the user to download will be a market booster. High costs and lack of coverage by certain insurance providers are few barriers to the market's growth.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of diabetes pen. The growth and trends of diabetes pen industry provide a holistic approach to this study.
Market Segmentation
This section of the diabetes pen market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Indication
- Type I Diabetes
- Type II Diabetes
- Pens
- Insulin Pen Needles
- Disposable
- Reusable
- Insulin
- Glucagon-like Peptide-1
- Growth Hormones
- Fertility
- Osteoporosis
- Others
- Hospitals
- Clinics
- Home Care Settings
This section covers the regional outlook, which accentuates current and future demand for the Diabetes Pen market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Diabetes Pen Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the diabetes pen market include AstraZeneca, BD, Eli Lilly and Company, Biocon, Sanofi, delfu-medical.com., Owen Mumford., Wockhardt Limited (India), Smiths Group plc, P&B Pharmaceuticals Ltd., Nipro Medical Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
METHODOLOGY:
This market research report has been produced by gathering information based on primary and secondary research. Secondary research has been done using various sources, including (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. Additionally, our team conducts extensive primary research with key industry participants to gather first-hand data. The data is then analyzed and validated by industry experts.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . DIABETES PEN – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 By Indication
3.7.2 By Product Type
3.7.3 By Types
3.7.4 By Therapy
3.7.5 By End Users
3.7.6 By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL DIABETES PEN MARKET ANALYSIS BY INDICATION
6.1 Overview by Indication
6.2 Historical and Forecast Data
6.3 Analysis by Indication
6.4 Type I Diabetes Market by Regions
6.5 Type II Diabetes Market by Regions
7 . GLOBAL DIABETES PEN MARKET ANALYSIS BY PRODUCT TYPE
7.1 Overview by Product Type
7.2 Historical and Forecast Data
7.3 Analysis by Product Type
7.4 Pens Market by Regions
7.5 Insulin Pen Needles Market by Regions
8 . GLOBAL DIABETES PEN MARKET ANALYSIS BY TYPES
8.1 Overview by Types
8.2 Historical and Forecast Data
8.3 Analysis by Types
8.4 Disposable Market by Regions
8.5 Reusable Market by Regions
9 . GLOBAL DIABETES PEN MARKET ANALYSIS BY THERAPY
9.1 Overview by Therapy
9.2 Historical and Forecast Data
9.3 Analysis by Therapy
9.4 Insulin Market by Regions
9.5 Glucagon-like Peptide-1 Market by Regions
9.6 Growth Hormones Market by Regions
9.7 Fertility Market by Regions
9.8 Osteoporosis Market by Regions
9.9 Others Market by Regions
10 . GLOBAL DIABETES PEN MARKET ANALYSIS BY END USERS
10.1 Overview by End Users
10.2 Historical and Forecast Data
10.3 Analysis by End Users
10.4 Hospitals Market by Regions
10.5 Clinics Market by Regions
10.6 Home Care Settings Market by Regions
11 . GLOBAL DIABETES PEN MARKET ANALYSIS BY GEOGRAPHY
11.1. Regional Outlook
11.2. Introduction
11.3. North America
11.3.1. Overview, Historic and Forecast Data
11.3.2. North America By Segment
11.3.3. North America By Country
11.3.4. United State
11.3.5. Canada
11.3.6. Mexico
11.4. Europe
11.4.1. Overview, Historic and Forecast Data
11.4.2. Europe by Segment
11.4.3. Europe by Country
11.4.4. United Kingdom
11.4.5. France
11.4.6. Germany
11.4.7. Italy
11.4.8. Russia
11.4.9. Rest Of Europe
11.5. Asia Pacific
11.5.1. Overview, Historic and Forecast Data
11.5.2. Asia Pacific by Segment
11.5.3. Asia Pacific by Country
11.5.4. China
11.5.5. India
11.5.6. Japan
11.5.7. South Korea
11.5.8. Australia
11.5.9. Rest Of Asia Pacific
11.6. Latin America
11.6.1. Overview, Historic and Forecast Data
11.6.2. Latin America by Segment
11.6.3. Latin America by Country
11.6.4. Brazil
11.6.5. Argentina
11.6.6. Peru
11.6.7. Chile
11.6.8. Rest of Latin America
11.7. Middle East & Africa
11.7.1. Overview, Historic and Forecast Data
11.7.2. Middle East & Africa by Segment
11.7.3. Middle East & Africa by Country
11.7.4. Saudi Arabia
11.7.5. UAE
11.7.6. Israel
11.7.7. South Africa
11.7.8. Rest Of Middle East And Africa
12 . COMPETITIVE LANDSCAPE OF THE DIABETES PEN COMPANIES
12.1. Diabetes Pen Market Competition
12.2. Partnership/Collaboration/Agreement
12.3. Merger And Acquisitions
12.4. New Product Launch
12.5. Other Developments
13 . COMPANY PROFILES OF DIABETES PEN INDUSTRY
13.1. Company Share Analysis
13.2. Market Concentration Rate
13.3. AstraZeneca
13.3.1. Company Overview
13.3.2. Financials
13.3.3. Products
13.3.4. Recent Developments
13.4. BD
13.4.1. Company Overview
13.4.2. Financials
13.4.3. Products
13.4.4. Recent Developments
13.5. Eli Lilly and Company
13.5.1. Company Overview
13.5.2. Financials
13.5.3. Products
13.5.4. Recent Developments
13.6. Biocon
13.6.1. Company Overview
13.6.2. Financials
13.6.3. Products
13.6.4. Recent Developments
13.7. Sanofi
13.7.1. Company Overview
13.7.2. Financials
13.7.3. Products
13.7.4. Recent Developments
13.8. Delfu-medical.com
13.8.1. Company Overview
13.8.2. Financials
13.8.3. Products
13.8.4. Recent Developments
13.9. Owen Mumford
13.9.1. Company Overview
13.9.2. Financials
13.9.3. Products
13.9.4. Recent Developments
13.10. Wockhardt Limited (India)
13.10.1. Company Overview
13.10.2. Financials
13.10.3. Products
13.10.4. Recent Developments
13.11. Smiths Group plc
13.11.1. Company Overview
13.11.2. Financials
13.11.3. Products
13.11.4. Recent Developments
13.12. P&B Pharmaceuticals Ltd.
13.12.1. Company Overview
13.12.2. Financials
13.12.3. Products
13.12.4. Recent Developments
13.13. Nipro Medical Corporation
13.13.1. Company Overview
13.13.2. Financials
13.13.3. Products
13.13.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Indication (USD MN)
- Type I Diabetes Market by Geography (USD MN)
- Type II Diabetes Market by Geography (USD MN)
- Analysis Market by Product Type (USD MN)
- Pens Market by Geography (USD MN)
- Insulin Pen Needles Market by Geography (USD MN)
- Analysis by Types (USD MN)
- Disposable Market by Geography (USD MN)
- Reusable Market by Geography (USD MN)
- Analysis by Therapy (USD MN)
- Insulin Market by Geography (USD MN)
- Glucagon-like Peptide-1 Market by Geography (USD MN)
- Growth Hormones Market by Geography (USD MN)
- Fertility Market by Geography (USD MN)
- Osteoporosis Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Analysis by End Users (USD MN)
- Hospitals Market by Geography (USD MN)
- Clinics Market by Geography (USD MN)
- Home Care Settings Market by Geography (USD MN)
- Global Diabetes Pen Market by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisiton
LIST OF FIGURES
- Research Scope of Diabetes Pen Report
- Market Research Process
- Market Research Methodology
- Global Diabetes Pen Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Indication
- Market Attractiveness Analysis by Product Type
- Market Attractiveness Analysis by Types
- Market Attractiveness Analysis by Therapy
- Market Attractiveness Analysis by End Users
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Indication (USD MN)
- Type I Diabetes Market by Geography (USD MN)
- Type II Diabetes Market by Geography (USD MN)
- Global Market Analysis by Product Type (USD MN)
- Pens Market by Geography (USD MN)
- Insulin Pen Needles Market by Geography (USD MN)
- Global Market Analysis by Types (USD MN)
- Disposable Market by Geography (USD MN)
- Reusable Market by Geography (USD MN)
- Global Market Analysis by Therapy (USD MN)
- Insulin Market by Geography (USD MN)
- Glucagon-like Peptide-1 Market by Geography (USD MN)
- Growth Hormones Market by Geography (USD MN)
- Fertility Market by Geography (USD MN)
- Osteoporosis Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Global Market Analysis by End Users (USD MN)
- Hospitals Market by Geography (USD MN)
- Clinics Market by Geography (USD MN)
- Home Care Settings Market by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Company Market Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Related Categories
Medical Devices
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments